Japanese health authorities will soon make a decision on a possible penalty against the local unit of Swiss pharmaceutical giant Novartis for failing to report drug side effects in more than 3,000 cases that may have been caused by about two dozen company drugs. The regulators would slap a 15-day suspension order on the firm, meaning the company could not sell most of its drugs during the two-week period. A spokesman said, "We haven't decided anything yet, but it ...
Read More
You have just read an article categorized health
titled Novartis Japan Will Face Penalty Over Failing to Report Drug Side Effects.
Written by:
editor -
Wednesday, February 4, 2015
There are currently no comments for "Novartis Japan Will Face Penalty Over Failing to Report Drug Side Effects"
Post a Comment